Dana-Farber Cancer Institute Inc
Dana-Farber Cancer Institute Inc is a public charity based in Boston, Massachusetts. It provides cancer care and advances cancer research, with its mission also encompassing education, outreach, advocacy, and efforts to reduce the impact of cancer.
Key facts about Dana-Farber Cancer Institute Inc
In short: Dana-Farber Cancer Institute Inc gave $4.4M across 34 grants in 2025 (avg $129K), mostly in Massachusetts. 41% of 2025 grantees were new. Source: 2025 IRS Form 990.
- EIN
- 04-2263040
- Latest 990 filing
- Form 990, 2025
- Annual giving (2025)
- $4,395,981
- Grants made (2025)
- 34
- Average grant
- $129,294
- Median grant
- $15,000
- New grantees (estimate)
- 41% first-time grantees (14 of 34, 2025)
- Total assets
- $5,997,012,444
- Primary geography
- Massachusetts (97% of itemized 2025 grant dollars)
Data from IRS Form 990, 2025; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
Financial Overview
From 2025 IRS Form 990 · View filing
Total Assets
$6.0B
+12.1% YoY
Annual Giving
$4.4M
+5.7% YoY
Grant Count
34
+13.3% YoY
Avg Grant Size
$129K
-6.7% YoY
Is Dana-Farber Cancer Institute Inc open to new grantees?
41%
first-time grantees, 2025
In 2025, 14 of 34 grantees (41%) were first-time recipients. First grants averaged $37K; repeat grants $194K. How we count
Medians: $13K first-time, $18K repeat.
- 44% of 2025 grantees were also funded in 2024. Method
- Giving held roughly steady from 2022 to 2025 (+2%). Method
Estimate from itemized grant lists in IRS Form 990 filings (2019–2025). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Mission & Focus Areas
Dana-Farber’s stated mission is to provide expert, compassionate, and equitable care to children, adults, and their families while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. It also trains clinicians and scientists, shares therapies and discoveries, and works to reduce cancer’s impact, with a focus on communities that have been historically marginalized.
The Institute’s 2025 grants included support for cancer research and development and community support. Examples of grantees’ work include Harvard’s education and research across academic fields; Alternatives for Community and Environment’s work against environmental racism and classism; and FamilyAid Boston’s support for parents and caregivers experiencing homelessness. GreenRoots works on environmental justice and community quality of life, while Project Bread works to prevent hunger. These are descriptions of the grantees’ missions.
Grantmaking
In filing year 2025, Dana-Farber reported 34 grants totaling $4,395,981. Grants ranged from $5,500 to $1,692,833, with a median of $15,000. The largest awards included $1,692,833 to the City of Boston for community support and $1,493,414 to Harvard University for cancer research and development. Other notable 2025 grants included $199,998 to Alternatives for Community and Environment, $184,236 to FamilyAid Boston, and $100,000 each to Project Bread and GreenRoots, all for community support.
Dana-Farber’s website says there are no funding opportunities open for general application at this time. It describes Meet the Moment as a one-time, $15 million investment over four years through the Determination of Need Community Health Initiative. The opportunity was launched for selected organizations with demonstrated effectiveness in serving priority communities; the site describes support for efforts in cancer prevention, access to care, and the social and economic conditions that influence health outcomes across Greater Boston.
Ready to take the next step with Dana-Farber Cancer Institute Inc?
Geographic Focus
Where this funder awards grants
In 2025, 97% of reported grant dollars went to recipients in Massachusetts. The reported shares for New York and Georgia were 1% each; Minnesota and California were each listed at 0%. The Institute’s website describes its community-health funding as addressing needs in its priority communities and, for Meet the Moment, across Greater Boston.
Grant Distribution by State
Share of 2025 grant dollars across all 34 itemized grants.
States
Cities
Giving Over Time
Total grant dollars and number of grants per year
From 2019 to 2025, annual grant giving ranged from $1.5M (2020) to $4.4M (2025). In 2025 it made 34 grants totaling $4.4M.
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
The largest 2025 recipient was City of Boston ($1.7M). Together the top 10 received $4.1M.
Grant Size Distribution
132 grants across all recorded years
The most common grant size was under $50K: 89 grants of 132 (67%).
Giving History
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| City of Boston Boston, MA | Community Support | $1,692,833 |
| Harvard University Cambridge, MA | Cancer Research and Development | $1,493,414 |
| Alternatives for Community Roxbury, MA | Community Support | $199,998 |
| FamilyAid Boston Boston, MA | Community Support | $184,236 |
| Boston Athletic Association Boston, MA | Community Support | $160,000 |
| Project Bread East Boston, MA | Community Support | $100,000 |
| Greenroots Inc Chelsea, MA | Community Support | $100,000 |
| Friends of Dana Farber Boston, MA | Cancer Research and Development | $50,000 |
| Conference Of Boston Teaching Hospitals Boston, MA | Community Support | $50,000 |
| Health Equity Compact Inc Boston, MA | Community Support | $50,000 |
Financial History
Multi-year comparison from IRS filings
| Filing year | Assets | Revenue | Expenses | Grants reported |
|---|---|---|---|---|
| 2025 | $5,997,012,444 | $3,917,771,259 | $3,825,086,627 | $4,395,981 |
| 2024 | $5,348,876,627 | $3,471,594,710 | $3,358,144,757 | $4,157,931 |
| 2023 | $4,735,245,065 | $3,387,587,769 | $3,002,803,859 | $3,971,297 |
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $5,997,012,444 | $5,348,876,627 | $4,735,245,065 |
| Revenue | $3,917,771,259 | $3,471,594,710 | $3,387,587,769 |
| Expenses | $3,825,086,627 | $3,358,144,757 | $3,002,803,859 |
| Net Investment Income | $4,786,266 | $5,694,108 | $4,887,533 |
Data update history
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS August 6, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS July 29, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS August 4, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS July 31, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS August 11, 2025)
- Added Form 990 for fiscal year 2019 (received by the IRS August 12, 2020)
- Added Form 990 for fiscal year 2025 (received by the IRS July 28, 2026)
- IRS filings on file for fiscal years 2020–2024
Leadership & Key People
Leadership team and compensation from IRS filings
The 2025 filing lists Benjamin Ebert, MD, PhD, as trustee, president, and CEO as of October 1, 2024. It lists Joshua Bekenstein as trustee and chairman, Lori Whelan as trustee and treasurer, Monica Chandra as trustee and secretary, and Richard Lubin as trustee and vice-chairman.
Dana-Farber Cancer Institute Inc is led by Barrett J Rollins MD PhD, Senior Advisor to President & CEO since 2024 (on filings since 2022); 21 of 89 officers listed in 2025 are compensated.
Officers on the 2025 filing
Barrett J Rollins MD PhD
Senior Advisor to President & CEO
Senior Advisor President CEO → Senior Advisor President & CEO, 2023
Senior Advisor President & CEO → Senior Advisor to President & CEO, 2024
On filings since 2022
50 hrs/week
$513K (2022) → $565K (2025)
Benjamin Ebert MD PhD
Trustee, President & CEO
Chair of Medical Oncology → Trustee, President & CEO, 2025
On filings since 2022
43 hrs/week
$200K (2022) → $468K (2025)
Laurie H Glimcher MD
President & CEO Emerita
Trustee, President & CEO → President & CEO Emerita, 2025
On filings since 2022
50 hrs/week
$3.7M (2022) → $2.3M (2025)
Scott Armstrong MD PhD
Chair of Pediatric Oncology
On filings since 2023
50 hrs/week
$801K (2023) → $843K (2025)
Joshua Bekenstein
Trustee & Chairman
Trustee Chairman → Trustee & Chairman, 2023
On filings since 2022
2 hrs/week
No compensation reported
Afsaneh Beschloss
Trustee
On filings since 2022
1 hr/week
No compensation reported
Alison Jaffe
Trustee
On filings since 2022
1 hr/week
No compensation reported
Amy Berylson
Trustee
On filings since 2022
1 hr/week
No compensation reported
Amy Kyle Esq.
Trustee
On filings since 2022
1 hr/week
No compensation reported
Andrew Janower
Trustee
On filings since 2022
1 hr/week
No compensation reported
Andrew Kaplan
Trustee
On filings since 2022
1 hr/week
No compensation reported
Beth Terrana
Trustee
On filings since 2022
1 hr/week
No compensation reported
Betty Ann Blum
Trustee
On filings since 2022
1 hr/week
No compensation reported
Bradley Lucas
Trustee
On filings since 2022
1 hr/week
No compensation reported
Brian Knez
Trustee
On filings since 2022
1 hr/week
No compensation reported
Christopher J Hadley
Trustee
On filings since 2022
1 hr/week
No compensation reported
Demond Martin
Trustee
On filings since 2022
1 hr/week
No compensation reported
Doug Grip
Trustee
On filings since 2022
1 hr/week
No compensation reported
Eric Miller
Trustee
On filings since 2022
1 hr/week
No compensation reported
Esta Stecher
Trustee
On filings since 2022
1 hr/week
No compensation reported
Fatima Penrose
Trustee
On filings since 2022
1 hr/week
No compensation reported
Frederica Williams
Trustee
On filings since 2022
1 hr/week
No compensation reported
Harvey Berger MD
Trustee
On filings since 2022
1 hr/week
No compensation reported
Hise Gibson
Trustee
On filings since 2022
1 hr/week
No compensation reported
James McCann
Trustee
On filings since 2022
1 hr/week
No compensation reported
Jane Brock-Wilson
Trustee
On filings since 2022
1 hr/week
No compensation reported
Jane Jamieson
Trustee
On filings since 2022
1 hr/week
No compensation reported
Jennifer Perini
Trustee
On filings since 2022
1 hr/week
No compensation reported
Jill Greenthal
Trustee
On filings since 2022
1 hr/week
No compensation reported
Jodi Walker
Trustee
On filings since 2022
1 hr/week
No compensation reported
Jose Aguerrevere
Trustee
On filings since 2022
1 hr/week
No compensation reported
Karen Daley PHD MPH RN FANN
Trustee
On filings since 2022
1 hr/week
No compensation reported
Karen Linde Packman
Trustee
On filings since 2022
1 hr/week
No compensation reported
Kate Gulliver
Trustee
On filings since 2022
1 hr/week
No compensation reported
Kevin DaSilva
Trustee
On filings since 2022
1 hr/week
No compensation reported
Kimberly Sherman Stamler
Trustee
On filings since 2022
1 hr/week
No compensation reported
Laura Sen
Trustee
On filings since 2022
1 hr/week
No compensation reported
Lisa Ferraro
Trustee
On filings since 2022
1 hr/week
No compensation reported
Lori Whelan
Trustee & Treasurer
Trustee → Trustee & Vice Chairman, 2023
Trustee & Vice Chairman → Trustee & Treasurer, 2024
On filings since 2022
2 hrs/week
No compensation reported
Louise Svanberg
Trustee
On filings since 2022
1 hr/week
No compensation reported
Meg Reynolds
Trustee
On filings since 2022
1 hr/week
No compensation reported
Michael Eisenson
Trustee
On filings since 2022
1 hr/week
No compensation reported
Michael Trotsky
Trustee
On filings since 2022
1 hr/week
No compensation reported
Monica Chandra
Trustee & Secretary
Trustee Secretary → Trustee & Secretary, 2023
On filings since 2022
1 hr/week
No compensation reported
Moria Forbes
Trustee
On filings since 2022
1 hr/week
No compensation reported
Nancy Gibson
Trustee
On filings since 2022
1 hr/week
No compensation reported
Nancy Lotane
Trustee
On filings since 2022
1 hr/week
No compensation reported
Paul Marcus
Trustee
On filings since 2022
1 hr/week
No compensation reported
Peter Palandjian
Trustee
On filings since 2022
1 hr/week
No compensation reported
Phillip Gross
Trustee
On filings since 2022
1 hr/week
No compensation reported
Richard Lubin
Trustee & Vice Chairman
Trustee Vice Chairman → Trustee & Vice Chairman, 2023
On filings since 2022
2 hrs/week
No compensation reported
Robert Reynolds
Trustee
On filings since 2022
1 hr/week
No compensation reported
Robert Stansky
Trustee
On filings since 2022
1 hr/week
No compensation reported
Ronald Sullivan
Trustee
On filings since 2022
1 hr/week
No compensation reported
Sandra Stratford MD
Trustee
On filings since 2022
1 hr/week
No compensation reported
Stephen Koster Esq.
Trustee
On filings since 2022
1 hr/week
No compensation reported
Steven Koppel
Trustee
On filings since 2022
1 hr/week
No compensation reported
Susan Alexander Esq.
Trustee
On filings since 2022
1 hr/week
No compensation reported
Susan Poduska
Trustee
On filings since 2022
1 hr/week
No compensation reported
Sushil Tuli
Trustee
On filings since 2022
1 hr/week
No compensation reported
Theodore Pasquarello
Trustee
On filings since 2022
1 hr/week
No compensation reported
Timothy Cohen
Trustee
On filings since 2022
1 hr/week
No compensation reported
Tracey McCain Esq.
Trustee
On filings since 2022
1 hr/week
No compensation reported
Elizabeth Clymer
Trustee
On filings since 2023
1 hr/week
No compensation reported
Frank Laukien PhD
Trustee
On filings since 2023
1 hr/week
No compensation reported
Gary Prado
Trustee
On filings since 2023
1 hr/week
No compensation reported
Levi Garraway MD PhD
Trustee
On filings since 2023
1 hr/week
No compensation reported
Elizabeth Rappaport
Trustee
New on the 2025 filing
1 hr/week
No compensation reported
Jessica Knez-Dulac
Trustee
New on the 2025 filing
1 hr/week
No compensation reported
Kenneth Lochiatto
Trustee
New on the 2025 filing
1 hr/week
No compensation reported
Payal Divakaran
Trustee
New on the 2025 filing
1 hr/week
No compensation reported
William Santis MD
Trustee
New on the 2025 filing
1 hr/week
No compensation reported
Bruce Johnson MD
Former
Senior Advisor to President CEO → Senior Advisor to President & CEO, 2023
Senior Advisor to President & CEO → Former, 2025
On filings since 2022
$671K (2022) → $291K (2025)
Craig A Bunnell MD MPH MBA
Chief Medical Officer
On filings since 2022
50 hrs/week
$762K (2022) → $1.1M (2025)
Jeffrey Meyerhardt MD MPH
Chief Clinical Research Officer
On filings since 2022
48 hrs/week
$489K (2022) → $753K (2025)
Jennifer Willcox Esq.
Assistant Secretary & General Counsel
Assistant Secretary Gc → Assistant Secretary & General Counsel, 2023
On filings since 2022
50 hrs/week
$498K (2023) → $872K (2025)
John O Chesley Esq.
Former Officer
Assistant Secretary Gc → Counsel, 2023
Counsel → Former Officer, 2025
On filings since 2022
$243K (2023) → $418K (2025)
Kevin Haigis PhD
Chief Scientific Officer
On filings since 2022
50 hrs/week
$525K (2022) → $692K (2025)
Maria Megdal
Senior Vice President Chief Administrative Officer
Senior Vice President of Institue Operations → Senior Vice President Chief Administrative Officer, 2023
On filings since 2022
50 hrs/week
$519K (2022) → $650K (2025)
Melany Duval
Senior Vice President & Chief Philanthropy Officer
Senior Vice President of Development → Senior Vice President & Chief Philanthropy Officer, 2023
On filings since 2022
50 hrs/week
$725K (2022) → $1.2M (2025)
Michael Constantine MD
Milford Med Dir-Hematology & Oncology
Milford Medical Director - Hematol Onc. → Milford Med Dir-Hematology & Oncology, 2023
On filings since 2022
50 hrs/week
$759K (2022) → $832K (2025)
Michael L Reney
CFO & Assistant Treasurer
CFO Assistant Treasurer → CFO & Assistant Treasurer, 2023
On filings since 2022
46 hrs/week
$835K (2022) → $1.2M (2025)
Robert Soiffer MD
Chief Clinical Program Officer
Chief of Hemotologic Malignancies → Chair Executive Committee for Clinical Programs, 2023
Chair Executive Committee for Clinical Programs → Chief Clinical Program Officer, 2025
On filings since 2022
50 hrs/week
$713K (2022) → $882K (2025)
Sylvia A Bartel RPh MHP
Senior Vice President of Pharmacy & Cpo
Vice President of Pharmacy Services → Senior Vice President of Pharmacy & Cpo, 2024
On filings since 2022
50 hrs/week
$322K (2022) → $374K (2025)
Wendy Gettleman
Vice President of Facilities Management & Real Estate
Vice President of Facilities Management Real Estate → Vice President of Facilities Management & Real Estate, 2023
On filings since 2022
50 hrs/week
$348K (2022) → $401K (2025)
William Hahn MD PhD
COO & Executive Vice President
COO Executive Vice President → COO & Executive Vice President, 2023
On filings since 2022
49 hrs/week
$855K (2022) → $1.5M (2025)
George D Demetri MD
Professor
New on the 2025 filing
50 hrs/week
$781K (2025)
Naomi Lenane
Senior Vice President Information Services CIO
New on the 2025 filing
50 hrs/week
$169K (2025)
Patrick McCormick
Senior Vice President Hospital Transformation
New on the 2025 filing
50 hrs/week
$394K (2025)
Former officers (121)
- Former: Elizabeth Liebow (2022–2024) — Former Key Employee
- Former: Eric Schlager (2022–2024) — Trustee
- Former: John J. O'Connor (2022–2024) — Trustee & Treasurer
- Former: Mary Ann Tocio (2022–2024) — Trustee
- Former: Robert Sachs (2022–2024) — Trustee
- Former: Stephen Fine (2022–2024) — Trustee
- Former: Karen Hale (2023–2024) — Trustee
- Former: Jessica Knez Dulac (2024) — Trustee
- Former: Jessica Knez (2022–2023) — Trustee
- Former: John Ryan Esq. (2022–2023) — Former Officer
- Former: Richard S Boskey Esq. (2022–2023) — Former Officer
- Former: Roger Berkowitz (2022–2023) — Trustee
- Former: Mary-Ellen Taplin MD (2023) — Chair Executive Committee for Clinical Research
- Former: Drew Memmott (2022) — Former Key Employee
- Former: Edward J Benz Jr. MD (2022) — President CEO Emeritus
- Former: Eric Winer MD (2022) — Chief of Div. of Women's Cancers
- Former: James D Griffin MD (2022) — Professor of Medicine
- Former: James Terwilliger (2022) — Former Officer
- Former: Joseph Norberg (2022) — Trustee
- Former: Matthew Meyerson MD (2022) — Professor
- Former: Roger Medel (2022) — Trustee
- Former: Alexander Susan Esq. (2019–2021) — Trustee
- Former: Bartel Sylvia R Ph MHP (2019–2021) — Vice President of Pharmacy Services
- Former: Bekenstein Joshua (2019–2021) — Trustee & Chairman
- Former: Benz Edward J Jr. MD (2019–2021) — President & CEO Emeritus
- Former: Berger Harvey MD (2019–2021) — Trustee
- Former: Berkowitz Roger (2019–2021) — Trustee
- Former: Berylson Amy (2019–2021) — Trustee
- Former: Beschloss Afsaneh (2019–2021) — Trustee
- Former: Blum Betty Ann (2019–2021) — Trustee
- Former: Boskey Richard S Esq. (2019–2021) — Assistant Secretary
- Former: Brock-Wilson Jane (2019–2021) — Trustee
- Former: Bunnell Craig A MD (2019–2021) — Chief Medical Officer
- Former: Chandra Monica (2019–2021) — Trustee & Secretary
- Former: Constantine Michael MD (2019–2021) — Milford Med Dir-Hematol Onc
- Former: Daley Karen Phd Mph Rn Fann (2019–2021) — Trustee
- Former: DaSilva Kevin (2019–2021) — Trustee
- Former: Duval Melany (2019–2021) — Senior Vice President of Development
- Former: Ebert Benjamin MD PhD (2019–2021) — Chair of Medical Oncology
- Former: Fine Stephen (2019–2021) — Trustee
- Former: Gettleman Wendy (2019–2021) — Vice President of Facilities Management
- Former: Gibson Nancy (2019–2021) — Trustee
- Former: Greenthal Jill (2019–2021) — Trustee
- Former: Griffin James D MD (2019–2021) — Professor of Medicine
- Former: Gross Phillip (2019–2021) — Trustee
- Former: Hadley Christopher (2019–2021) — Trustee
- Former: Jaffe Alison (2019–2021) — Trustee
- Former: Jamieson Jane (2019–2021) — Trustee
- Former: Janower Andrew (2019–2021) — Trustee
- Former: Johnson Bruce MD (2019–2021) — Chief Cl Res Officer
- Former: Kaplan Andrew (2019–2021) — Trustee
- Former: Knez Brian (2019–2021) — Trustee
- Former: Koppel Steven (2019–2021) — Trustee
- Former: Koster Stephen Esq. (2019–2021) — Trustee
- Former: Kyle Amy Esq. (2019–2021) — Trustee
- Former: Liebow Elizabeth (2019–2021) — Chief Strategy Officer
- Former: Lubin Richard (2019–2021) — Trustee & Vice Chairman
- Former: Lucas Bradley (2019–2021) — Trustee
- Former: Lucchino Lawrence (2019–2021) — Trustee
- Former: Marcus Paul (2019–2021) — Trustee
- Former: Martin Demond (2019–2021) — Trustee
- Former: McCain Tracey Esq. (2019–2021) — Trustee
- Former: Medel Roger MD (2019–2021) — Trustee
- Former: Megdal Maria (2019–2021) — Senior Vice President of Institute Operations
- Former: Memmott Drew (2019–2021) — Senior Vice President Research Administration
- Former: Miller Eric PhD (2019–2021) — Trustee
- Former: Norberg Joseph (2019–2021) — Trustee
- Former: O'Connor John (2019–2021) — Trustee & Treasurer
- Former: Packman Karen Linde (2019–2021) — Trustee
- Former: Palandjian Peter (2019–2021) — Trustee
- Former: Pasquarello Theodore (2019–2021) — Trustee
- Former: Perini Jennifer (2019–2021) — Trustee
- Former: Perlmutter Steven Esq. (2019–2021) — Trustee
- Former: Poduska Susan (2019–2021) — Trustee
- Former: Reynolds Robert (2019–2021) — Trustee
- Former: Rollins Barrett J MD PhD (2019–2021) — Snr Advisor to President & CEO
- Former: Sachs Robert Esq. (2019–2021) — Trustee
- Former: Schlager Eric (2019–2021) — Trustee
- Former: Sen Laura (2019–2021) — Trustee
- Former: Stansky Robert (2019–2021) — Trustee
- Former: Stecher Esta (2019–2021) — Trustee
- Former: Stone Richard M MD (2019–2021) — Professor of Medicine
- Former: Stratford Sandra Md Msc (2019–2021) — Trustee
- Former: Sullivan Ronald (2019–2021) — Trustee
- Former: Terrana Beth (2019–2021) — Trustee
- Former: Terwilliger James (2019–2021) — Former COO & Executive Vice President
- Former: Tocio Mary Ann (2019–2021) — Trustee
- Former: Tuli Sushil (2019–2021) — Trustee
- Former: Whelan Lori (2019–2021) — Trustee
- Former: Williams Frederica (2019–2021) — Trustee
- Former: Winer Eric MD (2019–2021) — Chief of Div of Wmns Cancers
- Former: Cohen Timothy (2020–2021) — Trustee
- Former: Glimcher Laurie H MD (2020–2021) — Trustee, President & CEO
- Former: Hahn William MD PhD (2020–2021) — COO & Executive Vice President
- Former: Lotane Nancy (2020–2021) — Trustee
- Former: Penrose Fatima (2020–2021) — Trustee
- Former: Reney Michael L (2020–2021) — CFO & Assistant Treasurer
- Former: Soiffer Robert MD (2020–2021) — Chief of Hemotologic Malig.
- Former: Svanberg Louise (2020–2021) — Trustee
- Former: Trotsky Michael (2020–2021) — Trustee
- Former: Walker Jodi (2020–2021) — Trustee
- Former: Eisenson Michael (2021) — Trustee
- Former: Forbes Moira (2021) — Trustee
- Former: Haigis Kevin (2021) — Chief Scientific Officer
- Former: McCann James (2021) — Trustee
- Former: Meyerhardt Jeffrey (2021) — Chief Cl Res Officer
- Former: Ryan John (2021) — Assistant Secretary
- Former: Armstrong Scott MD (2019–2020) — Chair of Pediatric Oncology
- Former: Bird Karen (2019–2020) — Former Officer
- Former: Cox Howard (2019–2020) — Trustee
- Former: Curtin Neal Esq. (2019–2020) — Trustee & Secretary
- Former: Dobson Sean (2019–2020) — Trustee
- Former: Paresky Susan (2019–2020) — Former Senior Vice President of Development
- Former: Puhy Dorothy (2019–2020) — Former COO & Executive Vice President
- Former: Yeshwant Krishna (2019–2020) — Trustee
- Former: Beale Jeffrey (2019) — Trustee
- Former: Farrington Thomas (2019) — Trustee
- Former: Glimcher Laurie MD (2019) — Trustee, President & CEO
- Former: LaTorre James (2019) — Trustee
- Former: Reney Michael (2019) — CFO & Assistant Treasurer
- Former: Ting David (2019) — Trustee
Data from IRS Form 990 filings, 2019–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $2.3M, to Laurie H Glimcher MD (President & CEO Emerita). 21 officers or directors reported compensation on that filing.
Contact
Mailing address: 450 Brookline Avenue Bp418, Boston, MA 02215
Phone: (617) 632-3000
Website: https://dana-farber.org
Frequently asked questions about Dana-Farber Cancer Institute Inc
How much does Dana-Farber Cancer Institute Inc give each year?
Dana-Farber Cancer Institute Inc gave $4.4M across 34 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $4.2M across 30 grants.
What is Dana-Farber Cancer Institute Inc's typical grant size?
Dana-Farber Cancer Institute Inc's median grant in 2025 was $15,000, and its average grant was $129,294, across 34 grants on its 2025 IRS Form 990. Organizations receiving their first grant from Dana-Farber Cancer Institute Inc that year got $37K on average.
Where does Dana-Farber Cancer Institute Inc give grants?
Dana-Farber Cancer Institute Inc gives mostly in Massachusetts: 97% of the grant dollars itemized on its 2025 IRS Form 990 went to recipients there. The most frequent recipient cities were Boston, MA (13 grants), Roxbury, MA (4 grants), New York, NY (2 grants) and Minneapolis, MN (2 grants).
Does Dana-Farber Cancer Institute Inc give general operating support?
Not in 2025: none of the 34 grants with a stated purpose on Dana-Farber Cancer Institute Inc's 2025 IRS Form 990 were described as general or operating support. Recurring purposes include "Community Support" (23 grants) and "Cancer Research and Development" (11 grants).
Who are Dana-Farber Cancer Institute Inc's largest grantees?
Dana-Farber Cancer Institute Inc's largest 2025 grantees include City of Boston ($1,692,833), Harvard University ($1,493,414) and Alternatives for Community ($199,998), according to its 2025 IRS Form 990. Together they received 77% of its itemized 2025 grant dollars.
How large is Dana-Farber Cancer Institute Inc?
Dana-Farber Cancer Institute Inc reported $6.0B in total assets on its 2025 IRS Form 990. Its revenue that year was $3.9B.
What does Dana-Farber Cancer Institute Inc fund?
Dana-Farber’s stated mission is to provide expert, compassionate, and equitable care to children, adults, and their families while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. See mission & focus areas ↑
How do I apply for a grant from Dana-Farber Cancer Institute Inc?
Dana-Farber Cancer Institute Inc has no public application process in the sources Grantable reviewed. Check dana-farber.org for current guidelines, or contact the foundation directly before submitting a request.
What is Dana-Farber Cancer Institute Inc's EIN?
Dana-Farber Cancer Institute Inc's EIN (Employer Identification Number) is 04-2263040. IRS Form 990 filing data is available on this page for 2019–2025.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Here's the math on researching Dana-Farber Cancer Institute Inc by hand.
Explore Open Grants
Browse active grant opportunities in Dana-Farber Cancer Institute Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Eastern Bank Foundation
Wakefield, MA
Eastern Bank Foundation supports economic inclusion and mobility, including small businesses, early childhood development, affordable housing, and workforce development. Its 2025 grants ranged from $50 to $2,002,500, with a median of $2,500, primarily in Massachusetts and also in New Hampshire and Rhode Island. It accepts online applications and does not limit giving to preselected organizations.
Assets
$266.7M
Grants
1,786
Total Given
$19.0M
Boston Foundation Inc
Boston, MA
The Boston Foundation funds nonprofits and community initiatives focused on equity and opportunity, including child well-being, economic opportunity, community wealth, and community leadership, primarily in Greater Boston. Its 2025 grants had a median of $25,000, while specific programs offer amounts such as $50,000; whether it accepts unsolicited requests is not stated.
Assets
$2.1B
Grants
2,375
Total Given
$228.4M
Children's Hospital Corporation
Boston, MA
Children’s Hospital Corporation funds pediatric healthcare, education, research, and community services, including grants to community organizations. In 2025, grants ranged from $6,000 to $2.69 million, with a median of $60,000; 99% of grant dollars went to Massachusetts recipients. The profile does not state whether it accepts unsolicited requests.
Assets
$9.1B
Grants
113
Total Given
$14.5M
Liberty Mutual Foundation Inc
Boston, MA
Liberty Mutual Foundation funds basic needs such as food and shelter, education and workforce development, and climate and community infrastructure, including homelessness and community preparedness programs. Its 2024 grants had a median of $35,000, and most funding supports organizations or programs serving the Boston area, though it also gives elsewhere. It accepts unsolicited online requests on a rolling basis, with no submission deadlines.
Assets
$46.1M
Grants
706
Total Given
$50.6M
Bushrod H Campbell & Adah F Hall
Boston, MA
The fund supports organizations serving older, infirm, homeless, and vulnerable people, as well as work in education, social justice, economic opportunity, and reproductive health. Grants generally focus on Greater Boston, with reproductive health projects also eligible elsewhere; typical grants are modest, with a 2025 median of $8,000 and a listed award range of $5,000–$10,000. It gives only to preselected organizations and does not accept unsolicited requests.
Assets
$15.6M
Grants
201
Total Given
$1.7M
Bristol-Myers Squibb Foundation Inc
Princeton, NJ
The Bristol-Myers Squibb Foundation supports health access and stronger health systems, with a focus on adult and pediatric cancers, blood disorders, brain health, and clinical-trial participation in the United States, Brazil, India, and ten Sub-Saharan African countries. In 2024, its median grant was about $134,000, though awards varied widely; it does not state whether it accepts unsolicited requests, and advises prospective applicants to contact the Foundation about its process.
Assets
$83.3M
Grants
144
Total Given
$67.7M
Barr Foundation
Boston, MA
The Barr Foundation funds arts and creativity, climate, education, and New England’s social sector, primarily through long-term support for organizations in New England. Its 2024 grants ranged from $100 to $3.275 million, with a median of $80,000. Its filing says it accepts only requests from preselected organizations and does not accept unsolicited requests, though its website describes program-page inquiries and occasional open calls.
Assets
$1.9B
Grants
903
Total Given
$123.2M
Cummings Foundation Grants Inc (FKA Oneworld Boston Inc)
Woburn, MA
Cummings Foundation Grants Inc. funds nonprofits working in human services, education, healthcare, fairness and justice, and the environment, primarily in greater Boston and eastern Massachusetts. Its 2024 grants ranged from $1,000 to $3.5 million, with a median of $35,000; it accepts letters of inquiry through an online portal during its application cycle, which was not open at the time described.
Assets
$258.2M
Grants
658
Total Given
$38.2M
American Tower Corporation Foundation
Boston, MA
Assets
$15.4M
Grants
632
Total Given
$1.7M
Good Sports Inc
Braintree, MA
Good Sports provides free sports equipment, footwear, and apparel to established schools and community organizations running ongoing youth sports and physical-activity programs in high-need communities; it serves all 50 states and Puerto Rico. In 2025, grants ranged from $5,004 to $229,133, with a median of $12,781. Youth programs and schools can apply through its community-organization application process.
Assets
$13.8M
Grants
619
Total Given
$11.2M
The Stephen Phillips Memorial Scholarship Fund Inc
Boston, MA
The fund awards need- and merit-based scholarships to full-time students pursuing bachelor’s degrees who permanently reside in Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, or Vermont; recipients may attend college anywhere in the United States. Awards generally range from $3,000 to $17,000, with typical annual awards of $6,000 to $10,000. It accepts applications through an online student portal; the profile does not describe other unsolicited requests.
Assets
$41.6M
Grants
520
Total Given
$5.1M
More Funders in Massachusetts
Dana-Farber Cancer Institute Inc down — hundreds of funders to go?